ARLINGTON, Va.--(BUSINESS WIRE)--
CACI International Inc (NYSE:CACI)
announced today that it was awarded a blanket purchase agreement (BPA)
to provide support services to the Drug Enforcement Administration
(DEA). This BPA represents continuing work for CACI in its Business
Systems market area.
The DEA enforces the controlled substances laws and regulations of the
United States, and recommends and supports non-enforcement programs
aimed at reducing the availability of illicit controlled substances.
Under this BPA, CACI will support DEA’s enforcement and demand reduction
mission, both domestically and internationally, with onsite financial
and acquisition management system support; system administration and
development for DEA’s financial data warehouse system and internal
intranet sites; travel system project management, analysis, and
training; and financial policy support. CACI will also support the
development and implementation of new and improved business systems and
operating procedures to help to ensure DEA’s continued success in
complying with federal financial and acquisition management laws,
regulations, and policies.
DeEtte
Gray, President of U.S. Operations, said, “This award demonstrates
CACI’s proven solutions and services for financial, acquisition, and
property support areas. We are proud to continue our work with this
important customer, delivering successful enterprise business system
services that support the men and women of the DEA who enforce our
nation’s controlled substances laws.”
CACI provides information solutions and services in support of national
security missions and government transformation for Intelligence,
Defense, and Federal Civilian customers. CACI is a member of the Fortune
1000 Largest Companies, the Russell 2000 Index, and the S&P SmallCap600
Index. CACI’s sustained commitment to ethics and integrity defines its
corporate culture and drives its success. With approximately 18,600
employees worldwide, CACI provides dynamic career opportunities for
military veterans and industry professionals to support the nation’s
most critical missions. Join us! www.caci.com.
There are statements made herein which do not address historical
facts, and therefore could be interpreted to be forward-looking
statements as that term is defined in the Private Securities Litigation
Reform Act of 1995. Such statements are subject to factors that could
cause actual results to differ materially from anticipated results. The
factors that could cause actual results to differ materially from those
anticipated include, but are not limited to, the risk factors set forth
in CACI’s Annual Report on Form 10-K for the fiscal year ended June 30,
2017, and other such filings that CACI makes with the Securities and
Exchange Commission from time to time. Any forward-looking statements
should not be unduly relied upon and only speak as of the date hereof.These statements are not to be construed as an endorsement by the
Drug Enforcement Administration.
CACI-Awards

View source version on businesswire.com: http://www.businesswire.com/news/home/20171221005058/en/
CACI International Inc
Corporate Communications and Media:
Jody
Brown, Executive Vice President, Public Relations
703-841-7801
jbrown@caci.com
or
Investor
Relations:
David Dragics, Senior Vice President, Investor Relations
866-606-3471
ddragics@caci.com
Source: CACI International Inc